Agammaglobulinemia in a horse with evidence of functional T lymphocytes.

The study focuses on diagnosing agammaglobulinemia, a rare immune disorder, in a one-year-old Thoroughbred horse based on a series of clinical observations and tests. The study suggests that the immune disorder observed in the horse is similar to the condition in humans and unlike other immuno-deficiencies found in animals.

Diagnosis of Agammaglobulinemia

1. The diagnosis of agammaglobulinemia in the horse was based on several observations. These included a lack of serum immunoglobulins M, A, and G(T), as well as scant quantities of serum immunoglobulin G measured at 16 mg/100 ml. Serum immunoglobulins are antibodies that play a crucial role in the body’s immune response.
2. Further, the horse’s serum did not show the presence of specific antibodies following immunization and exposure to two antigens. The absence of specific antibodies implies that the immune system did not respond effectively to the administered vaccines.
3. The horse also showed no plasma cells, primary follicles, or germinal centers in a lymph node that was removed after antigenic stimulation. These elements are significant for an immune response, their absence indicative of a compromised immune system.
4. The horse lacked naturally occurring serum antibodies to rabbit erythrocytes. Age-matched control horses showed easily detectable levels of these antibodies. The absence of these antibodies signals a deficient immune response.
5. Lastly, the horse was found to be more susceptible to infections – a common characteristic of agammaglobulinemia due to the compromised immune functionality.

Evidence of Functional Cell-Mediated Immunity

1. Despite the agammaglobulinemia diagnosis, the horse showed signs of functional cell-mediated immunity. This included skin responses to injected phytolectins, skin response to antigen challenge after sensitization, and an in vitro proliferative response of lymph node cells to phytohemagglutinin.
2. The horse’s cell-mediated immunity was intact, as indicated by its survival to 17 months of age without antibody production. As a comparison, horses lacking both antibody production and cell-mediated immunity typically die by 4 months of age without immunologic intervention.

Comparison with Human Agammaglobulinemia

1. The researchers concluded that the documented features of agammaglobulinemia in this horse are similar to those in sex-linked agammaglobulinemia in humans. This is a significant finding as it links the immune disorder in this particular horse to a similar condition in humans.
2. The study also underscores how the horse’s version of the disorder is unique among immuno-deficiencies in animals, thus marking it as a potential area of further study on animal immune disorders.